BDBM36351 CID148124 Docetaxel
- Machulkin, AE; Uspenskaya, AA; Zyk, NY; Nimenko, EA; Ber, AP; Petrov, SA; Shafikov, RR; Skvortsov, DA; Smirnova, GB; Borisova, YA; Pokrovsky, VS; Kolmogorov, VS; Vaneev, AN; Ivanenkov, YA; Khudyakov, AD; Kovalev, SV; Erofeev, AS; Gorelkin, PV; Beloglazkina, EK; Zyk, NV; Khazanova, ES; Majouga, AG PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation. Eur J Med Chem 227: (2022)
- Buchholz, S; Schally, AV; Engel, JB; Hohla, F; Heinrich, E; Koester, F; Varga, JL; Halmos, G Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel. Proc Natl Acad Sci U S A 104: 1943-6 (2007)
- Wen, X; Zheng, P; Ma, Y; Ou, Y; Huang, W; Li, S; Liu, S; Zhang, X; Wang, Z; Zhang, Q; Cheng, W; Lin, R; Li, H; Cai, Y; Hu, C; Wu, N; Wan, L; Pan, T; Rao, J; Bei, X; Wu, W; Jin, J; Yan, J; Liu, G Salutaxel, a Conjugate of Docetaxel and a Muramyl Dipeptide (MDP) Analogue, Acts as Multifunctional Prodrug That Inhibits Tumor Growth and Metastasis. J Med Chem 61: 1519-1540 (2018)
- Cui, J; Meng, Q; Zhang, X; Cui, Q; Zhou, W; Li, S Design and Synthesis of Newa-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression. J Med Chem 58: 3534-47 (2015)
- Byun, WS; Lim, H; Hong, J; Bae, ES; Lee, SB; Kim, Y; Lee, J; Lee, SK; Hong, S Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer. J Med Chem 66: 3106-3133 (2023)